Agile Therapeutics: Positive Study Moves Company Closer To NDA Resubmission [Seeking Alpha]
Agile Therapeutics, Inc. (AGRX)
Last agile therapeutics, inc. earnings: 5/2 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.agiletherapeutics.com/investor-relations
Company Research
Source: Seeking Alpha
Agile Therapeutics: Positive Study Moves Company Closer To NDA Resubmission Summary Agile Therapeutics just released positive results for their Twirla adhesion study. Twirla was able to demonstrate a noninferiority to the comparator Xulane. Bulls vs. Bears.I provide some arguments for both sides. AGRX is speculative stock, so investors should know both sides the stock's story. Agile plans to resubmit Twirla's NDA in the first half of 2019. I take a look at the Twirla timeline in 2019 and share my plans for my AGRX shares. On February 11 reported Figure 1: Twirla noninferiority vs Xulane (Source Even though the share price has almost doubled since the beginning of 2019, investors should be optimistic about more gains ahead. This news should hopefully now trigger a series of positive catalysts between now and the end of 2019 as the company progresses Twirla towards a potential FDA approval. In my view, the bulls now have more to look forward to than the bears do. I intend to outline the
Show less
Read more
Impact Snapshot
Event Time:
AGRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AGRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AGRX alerts
High impacting Agile Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
AGRX
News
- Agile Therapeutics, Inc. (NASDAQ: AGRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Agile Therapeutics, Inc. (NASDAQ: AGRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Agile Therapeutics, Inc. (NASDAQ: AGRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Agile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate UpdateGlobeNewswire
AGRX
Earnings
- 11/9/23 - Beat
AGRX
Sec Filings
- 4/9/24 - Form 8-K
- 3/28/24 - Form 10-K
- 3/28/24 - Form 8-K
- AGRX's page on the SEC website